London s Pharmaceutical Industry

Posted On Sep 16 2016 by

#pharmaceutical industries # London’s Pharmaceutical Industry The United Kingdom has a solid pharmaceutical sector that is driven by innovation and by a desire to make a real difference to people’s lives. According to the New York Times, approximately 20 per cent of the world’s best-selling drugs are manufactured in the UK. The British pharmaceutical industry has a particularly strong presence in London, since the country’s capital is known as one of the world’s top centres for innovation and for high-value industries Overview and recent trends of the London pharmaceutical sector The London pharmaceutical industry has been an established economic sector …


Global Pharmaceutical Industry – Statistics – Facts

Posted On Sep 15 2016 by

#pharmaceutical industries # Global Pharmaceutical Industry Global Pharmaceutical Industry – Statistics Facts Statistics and facts about the pharmaceutical industry worldwide The pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is evident. The total level of pharmaceutical revenue worldwide had reached nearly one trillion U.S. dollars. North America is responsible for the largest portion, generating more than 40 percent of these revenues. This is mostly due to the leading role of the U.S. pharmaceutical industry. But as in many other industries, the Chinese pharmaceutical sector shows the highest growth …


Pharmaceutical News, Industry Analysis, Market Research Reports – Pharmaceutical Business Review

Posted On Sep 14 2016 by

#pharmaceutical business # Pharmaceutical Business Review FDA approves Amgen’s BLINCYTO for pediatric acute lymphoblastic leukemia The US Food and Drug Administration (FDA) has approved Amgen’s supplemental Biologics License Application (sBLA) for BLINCYTO (blinatumomab) to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Regulatory Affairs News Biogen’s Alzheimer’s drug gets FDA fast-track status By PBR Staff Writer The US Food and Drug Administration (FDA) has granted fast track designation to Biogen’s investigational Alzheimer’s disease (AD) treatment aducanumab. Production Manufacturing Process Production News Singapore sees first case of …


OTC Industry News – Production – Manufacturing – Pharmaceutical Business Review

Posted On Sep 14 2016 by

#pharmaceutical business # On 30 June, Moberg Pharma announced the acquisition of three Over-The-Counter brands in the U.S. from Prestige Brands. The acquisition has now been completed. The purchase price amounted to $40 million. Production Manufacturing OTC News Galderma’s U.S. affiliate, Galderma Laboratories received approval from the U.S. Food and Drug Administration (FDA) for Differin Gel (adapalene gel 0.1%) as an over-the-counter (OTC) treatment for acne. Production Manufacturing OTC News Moberg Pharma has signed an agreement to acquire New Skin, Fiber Choice and PediaCare, three well-established Over-The-Counter brands in the U.S. from Prestige Brands. Production Manufacturing OTC News VANC Pharmaceuticals, …